ARch Biopartners Inc (QB) (ACHFF) Share Price

https://www.otcmarkets.com/stock/ACHFF

https://www.otcmarkets.com/stock/ACHFF

https://www.otcmarkets.com/stock/ACHFF

https://www.otcmarkets.com/stock/ACHFF

https://www.otcmarkets.com/stock/ACHFF

ACHFF
ARch Biopartners Inc (QB)
1.52
0.001 (0.07%)
Volume: 23,900
Day Range: 1.515 - 1.53
Last Trade Time: 3:52:20 PM EDT

ACHFF
ARch Biopartners Inc (QB)
1.57
0.01 (0.64%)
Volume: 11,500
Day Range: 1.565 - 1.5801
Last Trade Time: 3:53:15 PM EDT

ACHFF
ARch Biopartners Inc (QB)
1.50
0.00 (0.00%)
Volume: 18,400
Day Range: 1.495 - 1.5101
Last Trade Time: 3:58:44 PM EDT

ACHFF
ARch Biopartners Inc (QB)
1.38
-0.07 (-4.83%)
Volume: 11,400
Day Range: 1.38 - 1.45
Last Trade Time: 3:53:41 PM EDT

ACHFF
ARch Biopartners Inc (QB)
1.52
-0.01 (-0.65%)
Volume: 43,700
Day Range: 1.48 - 1.531
Last Trade Time: 3:57:08 PM EDT

ACHFF
ARch Biopartners Inc (QB)
1.60
0.00 (0.00%)
Volume: 38,976
Day Range: 1.5925 - 1.61
Last Trade Time: 3:54:50 PM EDT

ACHFF
ARch Biopartners Inc (QB)
1.5602
0.00 (0.00%)
Volume:

ACHFF
ARch Biopartners Inc (QB)
1.70
-0.14 (-7.61%)
Volume: 4,500
Day Range: 1.69 - 1.72
Last Trade Time: 3:52:38 PM EST

ACHFF
ARch Biopartners Inc (QB)
2.00
0.00 (0.00%)
Volume: 7,047
Day Range: 2.00 - 2.024
Last Trade Time: 3:51:23 PM EST

ACHFF
ARch Biopartners Inc (QB)
2.0973
0.0272 (1.31%)
Volume: 2,000
Day Range: 2.092 - 2.0973
Last Trade Time: 2:58:43 PM EST

ACHFF
ARch Biopartners Inc (QB)
2.37
0.034 (1.46%)
Volume: 15,670
Day Range: 2.272 - 2.37
Bid: 1.80
Ask: 2.57
Last Trade Time: 3:59:02 PM EDT
Total Trades: 14
ACHFF Detailed Quote

ACHFF
ARch Biopartners Inc (QB)
2.55
-0.0832 (-3.16%)
Volume: 1,000
Day Range: 2.55 - 2.55
Bid: 1.62
Ask: 3.63
Last Trade Time: 3:48:22 PM EDT
Total Trades: 2
ACHFF Detailed Quote

ACHFF
ARch Biopartners Inc (QB)
2.71
-0.0224 (-0.82%)
Volume: 2,400
Day Range: 2.7002 - 2.71
Bid: 0.6637
Ask: 3.10
Last Trade Time: 10:15:11 AM EDT
Total Trades: 8
ACHFF Detailed Quote

ARch Biopartners Inc (ACHFF)
2.3545 ? 0.0145 (0.62%)
Volume: 500 @06/03/22 11:50:48 AM EDT
Bid Ask Day's Range
2.28 2.37 2.3545 - 2.3545
ACHFF Detailed Quote

ARch Biopartners Inc (ACHFF)
2.3545 ? 0.0145 (0.62%)
Volume: 500 @06/03/22 11:50:48 AM EDT
Bid Ask Day's Range
2.28 2.37 2.3545 - 2.3545
ACHFF Detailed Quote

ARch Biopartners Inc (ACHFF)
3.07 ? -0.04 (-1.29%)
Volume: 1,200 @04/29/22 3:10:21 PM EDT
Bid Ask Day's Range
2.1 4.22 3.07 - 3.07
ACHFF Detailed Quote

ARch Biopartners Inc (ACHFF)
2.63 ? 0.02 (0.77%)
Volume: 2,500 @03/11/22 3:56:45 PM EST
Bid Ask Day's Range
1.78 3.57 2.63 - 2.66
ACHFF Detailed Quote

ARch Biopartners Inc (ACHFF)
2.86 ? 0.01201 (0.42%)
Volume: 7,600 @02/04/22 3:46:54 PM EST
Bid Ask Day's Range
2.8 2.87 2.815 - 2.86
ACHFF Detailed Quote

https://www.otcmarkets.com/stock/ACHFF

https://www.otcmarkets.com/stock/ACHFF

ARch Biopartners Inc (ACHFF)
2.57 ? -0.03 (-1.15%)
Volume: 54,740 @11/05/21 3:59:41 PM EDT
Bid Ask Day's Range
1.45 2.58 2.402 - 2.65
ACHFF Detailed Quote

ARch Biopartners Inc (ACHFF)
2.57 ? -0.03 (-1.15%)
Volume: 54,740 @11/05/21 3:59:41 PM EDT
Bid Ask Day's Range
1.45 2.58 2.402 - 2.65
ACHFF Detailed Quote

PhaseII Clinical trail Data locked end June, start of data analysis in late July
We should be hearing results very soon!

TORONTO, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), a clinical stage company developing new drug candidates for treating organ damage caused by inflammation, today provided an update that the analysis of the results of the Phase II trial of its lead drug LSALT peptide (Metablok) is ongoing and will be disclosed to the public following third-party, scientific peer review.

After the recruitment of the last patient into the trial in early May, the Company’s Phase II data team reconciled the patient data collected from the seven clinical sites that participated in the trial. The database containing the trial data was then locked at the end of June, which enabled the start of data analysis in late July. All of the Phase II clinical sites in Canada, the U.S. and Turkey have been officially closed.

In Phase II of covid19 clinical trails
https//clinicaltrails.gov/ct2/show/ntc04402957

From8K period ending 06/30/21
ARCH BIOPARTNERS INC.
Notes to Condensed Interim Consolidated Financial Statements Nine Months Ended June 30, 2021 and 2020 (Unaudited - See Notice of No Auditor Review)
1. DESCRIPTION OF OPERATIONS
Arch Biopartners Inc. (the “Company”) is a portfolio based biotechnology company focused on the development of innovative technologies that have the potential to make a significant medical or commercial impact. The Company works closely with the scientific community, universities and research institutions to advance and build the value of select preclinical technologies, develop the most promising intellectual property, and create value for its investors.

At present, the Company is focused on the clinical development of its lead drug candidate Metablok TM.
• Metablok TM - or ‘LSALT peptide’, has the potential to treat or prevent dipeptidase-1 (DPEP-1) mediated organ inflammation in the lungs, liver or kidneys which often results in organ damage or failure, including in the case of sepsis and COVID-19;

The Company has three additional technology platforms in its portfolio under development:
• AB569 - a new drug candidate for treating or preventing antibiotic resistant bacterial infections, primarily in the lungs, and wounds;

• Borg: Peptide-Solid Surface Interface - binding of proprietary peptides to solid metal and plastic surfaces to inhibit biofilm formation and reduce corrosion; and

• MetaMx TM - proprietary synthetic molecules that target brain tumour initiating cells and invasive glioma cells.
The Company owns, or has exclusive licensing rights on the intellectual property ("IP") emanating from the programs listed above.
The corporate headquarters are located in Toronto, Ontario.

ARch Biopartners Inc (ACHFF)
1.38 ? 0.05 (3.76%)
Volume: 6,565 @09/22/21 2:14:18 PM EDT
Bid Ask Day's Range
1.08 2.03 1.35 - 1.38
ACHFF Detailed Quote

This has really taken off. Otc volume is growing. So is the tsx volume. This one's going to do really well folks. I expect a 10 bagger from here minimum.

ARch Biopartners Inc (ACHFF)
1.4592 ? 0.1092 (8.09%)
Volume: 93,641 @08/13/21 3:58:41 PM EDT
Bid Ask Day's Range
1.42 1.49 1.36 - 1.5
ACHFF Detailed Quote

ARch Biopartners Inc (ACHFF)
1.062 ? 0.02 (1.92%)
Volume: 7,000 @07/09/21 3:10:13 PM EDT
Bid Ask Day's Range
1.01 1.08 1.04 - 1.062
ACHFF Detailed Quote

ARch Biopartners Inc (ACHFF)
1.062 ? 0.02 (1.92%)
Volume: 7,000 @07/09/21 3:10:13 PM EDT
Bid Ask Day's Range
1.05 1.07 1.04 - 1.062
ACHFF Detailed Quote

ARch Biopartners Inc (ACHFF)
1.04 ? 0.0 (0.00%)
Volume: 0 @-
Bid Ask Day's Range
1.1 1.13 - - -
ACHFF Detailed Quote

I AGREE, YES 'Arch Biopartners Inc. (ACHFF)'

Are you buying? These are great prices. This is an absolute gift at these prices. Low volume. 1 big seller with million+ shares was offloading otherwise it should be trading at $2.50+. I feel really strong about phase 2. All signs are pointing to a good result. Phase 2 should be done in a few weeks as well! This is a 10 bagger in the making. Minimum.

ARch Biopartners Inc (ACHFF)
1.00999 ? 0.01869 (1.89%)
Volume: 500 @04/30/21 2:47:05 PM EDT
Bid Ask Day's Range
0.6691 1.1 1.00999 - 1.00999
ACHFF Detailed Quote

ARch Biopartners Inc (ACHFF)
1.1 ? 0.04 (3.77%)
Volume: 550 @04/16/21 3:51:21 PM EDT
Bid Ask Day's Range
0.8262 3.12 1.1 - 1.1
ACHFF Detailed Quote

ARch Biopartners Inc (ACHFF)
1.0 ? -0.001 (-0.10%)
Volume: 125 @02/19/21 11:50:08 AM EST
Bid Ask Day's Range
0.75 1.03 1.0 - 1.0
ACHFF Detailed Quote

https://otcbb.swingtradebot.com/equities/ACHFF

https://pennystocks.news/otc/?symbol=ACHFF

ARch Biopartners Inc (ACHFF)
1.16641 ? 0.0 (0.00%)
Volume: 5 @12/07/20 10:17:36 AM EST
Bid Ask Day's Range
1.13 1.16 - - -
ACHFF Detailed Quote

Lmao tsnp is a pump n dump. I doubled my money and bought more arch. You should do the same.

UNLIKE THE RUNNER WE FOUND IN TSNP, ACHFF SURE TOOK A SHIT ON YOU DIDN'T IT?

ARch Biopartners Inc (ACHFF)
1.25819 ? 0.03819 (3.13%)
Volume: 1,100 @10/23/20 12:34:42 PM EDT
Bid Ask Day's Range
1.22 1.28 1.254 - 1.26
ACHFF Detailed Quote

Here are some links to the science:

https://www.cell.com/action/showPdf?pii=S0092-8674%2819%2930782-2

Webinar from couple of months ago:

https://zoom.us/rec/play/E3gBfzmmLQxW7REF-lo_sCBgfFTUYNb4RVEJ07Bqn1YON9BYH6iMrfY-pRhC-gI8vHGUke9CDgo9N1yJ.Xw6L63LsOdGdNOqz?startTime=1597762652000&_x_zm_rtaid=QM8d4WVVQZmMF1e0M9fkNQ.1602875790298.1b21cd13b51261456df8fa4dbba328a1&_x_zm_rhtaid=746

I dont evaluate science but from what i have gathered from people that do is that Cilastatin and the pipeline appears to be good without any red flags and the drug has the potential to be extended as treatment for colorectal carcinoma and acute lymphoid leukemia as well.

Management team is excellent. They have guys on the board who have sold companies for billions of dollars in the past (patrick vink & adrian haigh)

0 outstanding warrants

Positive phase 2 news can really move this thing. Exciting times thats for sure

Not much of video person, but if you have research paper DD on what ACHFF is doing, or DD papers you have found on the market size, applications and Bio-chem tech being used here I would love to have it. Thanks